Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel
CONCORD, NC, Oct. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Hydromer, Inc (OTC: HYDI), is thrilled to announce the formation of the Company's first Scientific Advisory Board and proudly introduce its inaugural member, Mr. Eric Becktel. With a rich and diverse background in the dynamic biotech industry, Mr. Becktel brings not only a wealth of experience and expertise but also a deep familiarity with our company and its industry.
Mr. Becktel's unique contribution is rooted in his longstanding association with our organization. For over a decade, he has been a dedicated advocate and unofficial ambassador, actively promoting our company and its mission. A crucial part of Hydromer’s T-Hexx Animal Health product line that was sold off in 2018, he was involved with new product developments and the international sales of the product. After the sale he has been a crucial part of the hand over liaison and the development of new green chemistry products.
Now, we are excited to welcome him aboard to offer his unparalleled expertise formally as a member of our Scientific Advisory Board.
Eric Becktel's impressive career spans over two decades, encompassing various pivotal roles in quality management, product development, and product management within the biotech sector. His international experience as a sales engineer and scientific advisor has garnered him multiple accolades for innovation and product development, highlighting his profound insights from product inception to market success. Working and advising for technology and innovation driven companies such as Priceline, Audi, Porsche, Goalplay, Clubspeed and product driven scientific companies such as Hydromer, National Bio Green + Sciences, Alps+MD, Advanced Clinical Solution and many others.
Beyond his corporate accomplishments, Mr. Becktel is also a dedicated educator, sharing his knowledge and passion by teaching pharmaceutical development and regulatory courses at Hellenic American University in Athens. His commitment to nurturing the growth of others aligns with his lifelong dedication to learning and mentorship.
Eric Becktel is a seasoned professional with a deep understanding of the biotech industry, clinical and healthcare markets, and best practices in quality management. He holds a Bachelor of Applied Sciences from the Fachhochschule Augsburg, an Executive MBA from the Technical University of Munich, and has pursued advanced University Graduate studies in Environmental/Clinical/Micro-Biology, Chemistry, and Physics.
"We are excited to announce the formation of our Scientific Advisory Board and welcome Eric Becktel as its inaugural member," said Mike Torti, CEO. "His extensive expertise, combined with his long-standing connection with our company, will undoubtedly be a valuable asset as we continue to drive success and innovation in the biotech sector and beyond."
With a legacy of four decades in the medical hydrophilic sector, Hydromer has consistently strived for product and service excellence. As we embark on a new chapter, the formation of our Scientific Advisory Board marks a significant milestone in our journey. The expertise of Mr. Eric Becktel and our future advisory team members will be pivotal in shaping the future of our company and the medical hydrophilic industry.
About Hydromer, Inc.
Hydromer® has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 40 years. As a trusted partner to large and small companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs. We are an FDA, GMP/ISO 13485, and ISO 9001 production facility located in Concord, North Carolina.
Forward Looking Statements
This press release contains forward-looking statements that are based on Hydromer’s current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and that could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Hydromer Inc.
800-326-5976
M.Torti@hydromer.com
